October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide ...
September 5, 2018 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission ...
August 24, 2018 — In a small study of military personnel who had suffered head trauma and had reported memory and mood ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron ...
May 17, 2018 — A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint ...
May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
May 3, 2018 — BWX Technologies Inc. signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope ...
April 10, 2018 — Researchers have developed a new imaging agent that could help guide and assess treatments for people ...
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear ...
February 21, 2018 — Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the ...
February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark ...
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2 ...
December 28, 2017 — In the December featured basic science article in The Journal of Nuclear Medicine, Belgian ...
October 27, 2017 — The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a ...
August 30, 2017 — ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary ...
August 16, 2017 — In the featured translational article in the August issue of The Journal of Nuclear Medicine ...
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET) radiotracer that is ...
July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...
June 20, 2017 — Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F ...